VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
OTC PK
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 54.27% | -22.34% | -11.59% | -52.88% | -35.96% |
| Total Depreciation and Amortization | 27.78% | 0.00% | -4.00% | 118.18% | 38.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.57% | -13.74% | -45.80% | -204.18% | 67.95% |
| Change in Net Operating Assets | -187.98% | -28.67% | -85.71% | 1,295.37% | 49.49% |
| Cash from Operations | -53.89% | 37.22% | -24.24% | -83.58% | -13.75% |
| Capital Expenditure | -- | -- | 100.00% | 69.15% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 100.00% | 95.79% |
| Cash from Investing | -- | -- | 100.00% | 2,462.19% | 95.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.89% | -- | -- | -- | -- |
| Cash from Financing | -23.83% | 995.33% | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.88% | 78.27% | -183.59% | 75.12% | 277.05% |